Cargando…

The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB

Objective: To measure the economic impacts of the longer pre-XDR-TB treatment regimen and the shorter BEAT-TB India regimen. Methods: In the current study, the economic impacts of the current 18-month pre-XDR-TB treatment regimen and the 6–9 month BEAT-TB regimen were evaluated using an economic mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muniyandi, Malaisamy, Ramesh, Paranchi Murugesan, Wells, William A., Alavadi, Umesh, Sahu, Suvanand, Padmapriyadarsini, Chandrasekaran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459879/ https://www.ncbi.nlm.nih.gov/pubmed/37624349 http://dx.doi.org/10.3390/tropicalmed8080411

Ejemplares similares

Cost Effectiveness of a Shorter Moxifloxacin Based Regimen for Treating Drug Sensitive Tuberculosis in India
por: Muniyandi, Malaisamy, et al.
Publicado: (2022)

Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and Uganda
por: Rosu, Laura, et al.
Publicado: (2023)

Estimating TB diagnostic costs incurred under the National Tuberculosis Elimination Programme: a costing study from Tamil Nadu, South India
por: Muniyandi, Malaisamy, et al.
Publicado: (2021)

A national-level analysis of life expectancy associated with the COVID-19 pandemic in India
por: Muniyandi, Malaisamy, et al.
Publicado: (2022)

Strategies to detect and manage latent tuberculosis infection among household contacts of pulmonary TB patients in high TB burden countries ‐ a systematic review and meta‐analysis
por: Sagili, Karuna Devi, et al.
Publicado: (2022)

Is intermittent short-course anti-TB regimen as efficient and safe as daily anti-TB regimen for treating childhood TB?
por: Bhaumik, Soumyadeep
Publicado: (2015)

Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy
por: Sweeney, Sedona, et al.
Publicado: (2020)

Profile and Response to Anti-Tuberculosis Treatment among Elderly Tuberculosis Patients Treated under the TB Control Programme in South India
por: Velayutham, Banu Rekha Vaithilingam, et al.
Publicado: (2014)

Enhancing TB Case Detection: Experience in Offering Upfront Xpert MTB/RIF Testing to Pediatric Presumptive TB and DR TB Cases for Early Rapid Diagnosis of Drug Sensitive and Drug Resistant TB
por: Raizada, Neeraj, et al.
Publicado: (2014)

Characteristics and Programme-Defined Treatment Outcomes among Childhood Tuberculosis (TB) Patients under the National TB Programme in Delhi
por: Satyanarayana, Srinath, et al.
Publicado: (2010)

Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
por: Chowdhury, Kona, et al.
Publicado: (2023)

UNITE4TB: a new consortium for clinical drug and regimen development for TB
por: Boeree, M. J., et al.
Publicado: (2021)

The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
por: Khan, Uzma, et al.
Publicado: (2019)

Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting
por: Chandrasekaran, Padmapriyadarsini, et al.
Publicado: (2018)

The Prevalence of Self-Reported Tuberculosis in the Andaman and Nicobar Islands, India: Evidence from the NFHS-IV and V
por: Thiruvengadam, Kannan, et al.
Publicado: (2023)

Experience of “One Stop TB Diagnostic Solution” Model in Engaging a Private Laboratory for End-to-End Diagnostic Services in the National TB Elimination Program in Hisar, India
por: Raju, Rajesh, et al.
Publicado: (2023)

Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extra pulmonary (EP) multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai in pre Bedaquiline (BDQ) era
por: Utpat, Ketaki V., et al.
Publicado: (2023)

Costs of TB services in India
por: Chatterjee, S., et al.
Publicado: (2021)

Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2015)

Bedaquiline, Delamanid, Linezolid, and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis
por: Padmapriyadarsini, Chandrasekaran, et al.
Publicado: (2022)

Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting
por: Cates, L., et al.
Publicado: (2021)

Linking HIV-Infected TB Patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in India
por: Raizada, Neeraj, et al.
Publicado: (2009)

Challenges in TB control and the anticipated COVID-19 third wave: Way forward
por: Padmapriyadarsini, C., et al.
Publicado: (2021)

Shorter TB treatment regimens should be safer as well
por: Rucsineanu, O., et al.
Publicado: (2023)

Curing TB with sunlight
por: Wells, William A.
Publicado: (2006)

TB Anywhere is TB Everywhere
por: Wortham, Jonathan M.
Publicado: (2018)

TB or not TB! That’s the question
por: Nugud, Ahmed, et al.
Publicado: (2019)

The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia
por: Shibabaw, Agumas, et al.
Publicado: (2020)

Assessment of Effective Anti-TB Regimens and Adverse Outcomes Related Risk Factors in the Elderly and Senile-Aged TB Patients
por: Guo, Jing, et al.
Publicado: (2023)

Case Report: Kanamycin Ototoxicity and MDR-TB Treatment Regimen
por: Mantefardo, Bahru, et al.
Publicado: (2021)

Cost of TB services: approach and summary findings of a multi-country study (Value TB)
por: Sweeney, S., et al.
Publicado: (2022)

Refining MDR-TB treatment regimens for ultra short therapy (TB-TRUST): study protocol for a randomized controlled trial
por: Weng, Taoping, et al.
Publicado: (2021)

Can Pan-TB shorter regimens be a promising hope for ending TB in India by 2025 in ongoing COVID-19 era?
por: Prasad, Rajendra, et al.
Publicado: (2022)

An influence of dew point temperature on the occurrence of Mycobacterium tuberculosis disease in Chennai, India
por: Krishnan, Rajendran, et al.
Publicado: (2022)

Early detection of Pre-XDR TB with line probe assay in a high TB burden country
por: Madukaji, Laura, et al.
Publicado: (2021)

Striking the Right Balance Determines TB or Not TB
por: BoseDasgupta, Somdeb, et al.
Publicado: (2014)

Scaling Up TB Screening and TB Preventive Treatment Globally: Key Actions and Healthcare Service Costs
por: Satyanarayana, Srinath, et al.
Publicado: (2023)

Patients direct costs to undergo TB diagnosis
por: de Cuevas, Rachel M. Anderson, et al.
Publicado: (2016)

Cost of TB prevention and treatment in the Philippines in 2017
por: Capeding, T. P. J., et al.
Publicado: (2022)

Cost of TB services in healthcare facilities in Kenya
por: Kairu, A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5rhoisngton6m45eier36plrem